CBD On OTC Industry Radar As Regulatory Questions Cloud Runway
Executive Summary
With US market of hemp- and CBD-containing supplements and food booming, likelihood is growing products made with ingredients will gain approval in the country to be marketed with consumer health indications, said consumer health business executives during a panel discussion at CHPA conference. Legalization of marijuana sales and use by some states and other countries also will influence future of CBD use in US consumer health products, they say.
You may also be interested in...
BioMedican Pitches Cannabinoid Biosynthesis Investing; Cultivated Market Sprouts More Deals
BioMedican needs support until it can begin generating revenues and conduct an IPO. Businesses already marketing cannabinoid supplements receive more funding, or in some cases are acquired, as well as expand distribution.
Safety First For Perrigo In CBD Market; ‘Long-Term’ Play Starts With Clinical Trials
Perrigo’s clinical trials on CBD likely will take years before resulting products help bring order to the market. During earnings presentation, CEO Murray Kessler says the trials aren’t intended to establish claims for CBD but are more a long-term effort to provide data to FDA.
Perrigo Exploring The CBD Opportunity
Perrigo doesn't want to miss out on the opportunity presented by CBD to offer consumers a new type of self-care product, according to the firm’s managing director, UK & Ireland, and International vice president, Neil Lister.